About FluoGuide
FluoGuide is a company based in Copenhagen (Denmark) founded in 2018. FluoGuide has raised $13.95 million across 5 funding rounds from investors including European Union and EIC Fund. The company has 11 employees. FluoGuide offers products and services including FG001 and Photothermal Treatment. FluoGuide operates in a competitive market with competitors including Augmedics, Proprio, eCential Robotics, MRI Interventions and Endomag, among others.
- Headquarter Copenhagen, Denmark
- Employees 11
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fluoguide.com
- Social LinkedIn X Facebook
- Legal Name Fluoguide A/S
- Net Profit-$6.35 M (USD)-31.8as on Dec 31, 2025
- EBITDA-$6.36 M (USD)-15.84as on Dec 31, 2025
- Total Equity Funding$13.95M (USD)
in 5 rounds
- Latest Funding Round$52.45K (USD), Grant
Jun 2022
- InvestorsEuropean Union
& 1 more
- Employee Count11
Products & Services of FluoGuide
FluoGuide offers a comprehensive portfolio of products and services, including FG001 and Photothermal Treatment.
Lights up cancerous tissue to guide precise surgery and improve outcomes.
Selectively destroys cancer cells in brain tumors while sparing healthy tissue.
Funding Insights of FluoGuide
FluoGuide has successfully raised a total of $13.95M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $52.45 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.95M
- Total Rounds 5
- Last Round Grant — $52,445
- First Round $2.33M
(Mar 2019)
- Investors Count 2
All 5 funding rounds of FluoGuide with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $52,445 | Grant | – | – | |
| May 2021 | $9M | Series B | $128.38M | – | – |
| Jul 2020 | $2.81M | Grant | – | – | |
| Feb 2020 | $2.62M | Series A | $9.22M | – | – |
| Mar 2019 | $2.33M | Series A | $••••• | – | – |
| Date | Valuation | Stage |
|---|---|---|
| May 2021 | $128.38M | •••••••• |
| Feb 2020 | $9.22M | •••••••• |
| Mar 2019 | $••••• | •••••••• |
Full valuation and stage history of FluoGuide
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $128.38M (May 2021). 2 investors in total: 2 institutional.
Investors in FluoGuide
FluoGuide has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for FluoGuide
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FluoGuide
9 people are tracked at FluoGuide (4 in leadership, 5 in board & advisors); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Henrik Moltke | CFO | Leadership |
Morten Albrechtsen | CEO | Leadership |
Grethe Nørskov Rasmussen | Chief Development officer | Leadership |
Dorthe Grønnegaard Mejer | VP, Clinical Development | Leadership |
Shomit Ghose | Board Member | Board & advisors |
Micaela Sjökvist | Board Member | Board & advisors |
Andreas Kjaer | Board Member | Board & advisors |
Mats Thorén | Vice Chairman | Board & advisors |
Peter Mørch Eriksen | Chairman | Board & advisors |
Complete people profiles for FluoGuide
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of FluoGuide
FluoGuide is a publicly listed company on the OMXSTO with ticker symbol FLUO in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 May 2019
- Listed onOMXSTO: FLUO
- Listed entityFluoGuide A/S
- Exchange sectorHealth technology
- ISINDK0061123312
- Share price32.10 SEK (-2.73% on the day) · 2026-10-09
- Market capitalisation539,527,353.00 SEK
- EPS (diluted, trailing year)-4.39 SEK
- Volume (last session)4,170
Financials of FluoGuide
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | – | -58.5M SEK | -58.6M SEK |
| 2024 | – | -44.4M SEK | -50.5M SEK |
| 2023 | – | -59.1M SEK | -67.9M SEK |
| 2022 | – | -39.1M SEK | -55.4M SEK |
| 2021 | – | -32.4M SEK | -52.2M SEK |
Detailed financial statements for FluoGuide
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of FluoGuide
5 dated milestones of FluoGuide across 4 years, from founding to its latest funding, stage changes and deals.
- Founded FluoGuide is founded.
- Funding First funding round of $2.3M.
- Milestone Reaches Minicorn status.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $52K.
Competitors of FluoGuide
FluoGuide operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, eCential Robotics, MRI Interventions and Endomag, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| augmedics.com | 2014 | Yokneam Illit, Israel | $142.6M | – | Augmented reality systems for guiding surgical procedures are developed. | |
| propriovision.com | 2016 | Seattle, United States | $74.25M | 52 | Visualization systems for surgical procedures are developed using machine learning. | |
| ecential-robotics.com | 2009 | Gieres, France | $133.97M | – | Robotic surgery platform for bone procedures is developed. | |
| mriinterventions.com | 1998 | Irvine, United States | $16.67M | 108 | MRI-guided minimally invasive procedures for brain and heart are developed. | |
| endomag.com | 2007 | Cambridge, United Kingdom | $44.52M | – | Developer of a device for tumor localization | |
| centerlinebiomedical.com | 2014 | Cleveland, United States | $76.26M | – | Developer of surgical navigation and image guidance system for endovascular procedures | |
| imris.com | 2005 | Minnetonka, United States | – | 100 | Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow | |
| avetasystem.com | 2016 | San Jose, United States | $23M | 57 | Manufacturer of hysteroscopy for operating rooms | |
| clearpointneuro.com | 1998 | Irvine, United States | $18.35M | 38 | Software and hardware solutions for MRI-guided surgical planning are provided. | |
| checkpointsurgical.com | 2009 | Cleveland, United States | $47.59M | 68 | Intraoperative neuromonitoring devices are provided for nerve and muscle evaluation. |
Detailed competitors of FluoGuide
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of FluoGuide
The website of FluoGuide (fluoguide.com) receives about 2K visits a month.
- Monthly visits2K
▲ 19.7% vs previous month
Latest news on Fluoguide
Complete news archive for FluoGuide
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to FluoGuide
10 companies that operate in the same segment as FluoGuide (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about FluoGuide
FluoGuide was founded in 2018 and raised its 1st funding round 1 year after it was founded.
FluoGuide is headquartered in Copenhagen, Denmark.
FluoGuide is a funded company, having raised a total of $13.95M across 5 funding rounds to date. The company's 1st funding round was a Series A of $2.33M, raised on Mar 2019.
FluoGuide has 11 employees.
FluoGuide was founded in 2018 in Copenhagen, Denmark, within the biotechnology sector focused on oncology. Drugs designed to target cancer cells during surgical procedures are developed by the company. The lead product, FG001, involves a fluorophore administered intravenously before surgery, which binds to uPAR-expressing cancer cells to highlight them and their invasion into adjacent tissue. Operations center on advancing these imaging agents for improved surgical outcomes in cancer treatment.
FluoGuide's top competitors include Augmedics, Proprio and ClearPoint Neuro.
FluoGuide offers FG001 and Photothermal Treatment.
Yes, FluoGuide is publicly traded on OMXSTO under the ticker symbol FLUO.
FluoGuide has 2 investors. Key investors include European Union, and EIC Fund.
The valuation of FluoGuide is $128.38M as of May 2021.
FluoGuide operates through Fluoguide A/S.